Everhart Financial Group Inc. increased its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 34.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 8,990 shares of the semiconductor company’s stock after acquiring an additional 2,328 shares during the quarter. Everhart Financial Group Inc.’s holdings in Lam Research were worth $1,204,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in LRCX. IMG Wealth Management Inc. purchased a new stake in Lam Research in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research during the 2nd quarter valued at $29,000. Delos Wealth Advisors LLC purchased a new stake in shares of Lam Research during the 2nd quarter valued at $30,000. Finally, REAP Financial Group LLC bought a new stake in shares of Lam Research during the 2nd quarter worth $31,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Multiple major brokers sharply raised targets (many to $275–$300), signaling broad analyst bullishness after the quarter and suggesting upside versus earlier prices. These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results
- Positive Sentiment: JPMorgan and Citigroup raised targets to $300 (overweight/buy), and firms including Needham, TD Cowen, Wells Fargo, Deutsche and Stifel also lifted targets — a strong institutional vote of confidence for continued AI/foundry-driven demand. Analyst target increases (Benzinga)
- Positive Sentiment: Lam beat Q2 estimates (EPS $1.27 vs. $1.17 est.; revenue $5.34B vs. $5.23B) and issued Q3 EPS guidance of $1.25–$1.45 and revenue above consensus — concrete operational drivers behind analyst upgrades. Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y
- Neutral Sentiment: New Street Research raised its target to $235 but kept a neutral rating, reflecting near-term upside limited relative to recent price strength. New Street adjusts price target on Lam Research to $235
- Negative Sentiment: HSBC raised its target to $221 but maintained a “hold,” which implies downside from recent levels and highlights some analyst caution despite better results. HSBC adjusts price target on Lam Research to $221
- Negative Sentiment: Coverage notes flag valuation concerns after a large run (high P/E and steep analyst target dispersion), which may limit further upside and explains some profit‑taking. Lam Research Earnings Beat Highlights AI Demand But Raises Valuation Questions
Lam Research Trading Down 5.9%
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the firm earned $0.91 earnings per share. The business’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s payout ratio is presently 21.31%.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Berenberg Bank increased their target price on Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Wells Fargo & Company increased their price objective on Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a research report on Thursday. HSBC raised their price objective on Lam Research from $181.00 to $221.00 and gave the company a “hold” rating in a report on Friday. Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, BNP Paribas Exane lifted their price target on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and a consensus target price of $238.32.
View Our Latest Report on Lam Research
Insider Activity
In related news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 41,408 shares of company stock worth $6,248,501 in the last quarter. 0.31% of the stock is owned by corporate insiders.
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories
- Five stocks we like better than Lam Research
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
